Affiliate Disclosure: This article is for informational purposes and does not replace consultation with your cardiologist or prescriber. We link to provider websites for factual transparency.
By UTCardiothoracicSurgery.com Editorial Team | Source date: August 5, 2026
Related reading: pde5 inhibitors blood pressure medications drug interactions.
Critical Cardiac and Drug Interaction Gates
⚠ ABSOLUTE CONTRAINDICATIONS: Do Not Combine With These Medications
- Organic nitrates (isosorbide, nitroglycerin, isosorbide mononitrate): According to approved sildenafil labeling, tadalafil prescribing information, and vardenafil prescribing information, PDE5 inhibitors can amplify the blood-pressure-lowering effects of nitrates, creating dangerous drops in blood pressure.
- Riociguat (Adempas): Used for pulmonary hypertension. Approved tadalafil and vardenafil labels contraindicate riociguat due to synergistic blood-pressure-lowering effects. Sildenafil labeling should be checked in your medical review.
- 5-HT3 antagonists (ondansetron/Zofran): The FDA-approved apomorphine injection label (APOKYN) documents that apomorphine combined with ondansetron caused profound hypotension and loss of consciousness in Parkinson's patients. This interaction reflects a real drug concern. Inform your prescriber if you take ondansetron.
What Are Compounded ED Medications?
Some telehealth ED programs offer compounded medications—prescription drugs prepared by licensed pharmacies according to a prescriber's order. According to the FDA's guidance on telehealth companies promoting compounded drugs, these products require careful oversight because they are not FDA-approved.
Unlike sildenafil (Viagra) or tadalafil (Cialis), which are FDA-approved single-ingredient tablets, some compounded offers combine multiple active ingredients into a sublingual (under-the-tongue) tablet or liquid. The following are examples from company sources:
Three Named Compounded ED Combination Examples
The following examples show the active ingredients and routes publicly listed by each telehealth provider. The descriptions come directly from company statements.
| Product/Offer | Public Ingredients | Route | Company |
|---|---|---|---|
| DirectMax | Apomorphine, sildenafil, tadalafil | Sublingual | Direct Meds (prescription products are filled by licensed third-party compounding pharmacies) |
| Keeps Powerhouse | Apomorphine, vardenafil, tadalafil | Sublingual | Keeps (clinician-matched compounded prescription offer) |
| Vital Man 4th Gear | Apomorphine, vardenafil, sildenafil, tadalafil | Sublingual | Vital Man (not FDA-approved, prepared for individual patients) |
Blood Pressure and Medication Review Checklist
Beyond absolute contraindications, compounded ED products require prescriber review for interactions with other medications. According to approved ED drug labels, the degree of risk depends on your medical condition, dose, and other medicines. Your prescriber must assess whether each combination is safe for you. Ask your prescriber about these categories:
- Alpha-blockers (doxazosin, tamsulosin, terazosin): Used for prostate symptoms or high blood pressure. Approved ED drug labels show PDE5 inhibitors add to the blood-pressure-lowering effects of these medications.
- Antihypertensive medications: ACE inhibitors, ARBs, beta-blockers, calcium-channel blockers, diuretics, and similar drugs reduce blood pressure. PDE5 inhibitors add to this effect.
- CYP3A4 inhibitor medications: Clarithromycin, erythromycin, ketoconazole, itraconazole, and ritonavir slow the breakdown of PDE5 inhibitors, raising their blood levels.
- Vardenafil-specific: Congenital QT syndrome or class IA and III antiarrhythmic medications: According to vardenafil prescribing information, patients with congenital QT syndrome or those taking class IA or III antiarrhythmics should avoid the orally disintegrating form. Your cardiologist must review this.
Cardiovascular Status: A Screening, Not a Barrier
Sexual activity increases the heart's workload. Approved PDE5 inhibitor labels direct prescribers to consider cardiovascular status because this is a screening issue before treatment begins. Your prescriber needs to know your health history so the decision can be made safely for your individual situation. For additional information, explore the connection between ED and cardiovascular health.
What Approved Labels Do and Don't Tell Us
Approved ED medications (sildenafil tablets, tadalafil tablets, vardenafil orally disintegrating tablets) have been studied in clinical trials and carry FDA-reviewed prescribing information. The DailyMed sources describe approved single-ingredient products and specific routes. They do not validate the absorption, strength, onset, duration, safety, or efficacy of a multi-active compounded sublingual tablet or liquid. When a pharmacy combines multiple ingredients into a sublingual form, the data from single-ingredient oral tablets do not automatically apply. Your prescriber must justify the compounded approach based on your individual case.
Emergency Symptoms: When to Seek Immediate Care
These symptoms require urgent medical evaluation or emergency care:
- Erection lasting more than 4 hours: Seek urgent evaluation.
- Sudden vision loss: Seek prompt medical attention.
- Sudden hearing loss: Seek prompt medical attention.
- Chest pain, fainting, or severe dizziness during sexual activity: Seek urgent care immediately.
In any emergency, inform the medical team about any recent ED medication use. Call 911 if needed.
What to Bring to Your Medical Review
Before you start any compounded ED medication, have a complete medication review with your doctor. Bring a list of:
- All prescription medications, including doses
- All over-the-counter medications and supplements
- Any history of heart disease, high blood pressure, stroke, or irregular heartbeat
- Recent blood pressure and heart rate readings if available
- A summary of previous ED treatments and your response
- Any history of vision or hearing problems with ED medications
A complete prescriber review ensures your individual medical history guides the decision. See the article on why a single ED treatment may fail for more on medical evaluation.
Frequently Asked Questions
Q: Is a compounded ED medication safer than a single-ingredient prescription like Viagra?
A: A compounded combination is not FDA-approved and has not undergone the same FDA review as Viagra (sildenafil) or Cialis (tadalafil). The sources reviewed for this article did not include a clinical trial of the exact combination and route described by these offers. This is an individual clinical decision that your prescriber must make based on your medical history and current medicines.
Q: Why can't I take my nitroglycerin if I'm on a compounded ED product?
A: According to approved drug labels, PDE5 inhibitors can amplify the blood-pressure-lowering effects of nitrates, causing a dangerous drop in blood pressure. If you have chest pain and need nitroglycerin while on any ED product, tell the emergency team immediately about the ED medication so they can manage your blood pressure appropriately.
Q: I'm on a blood pressure medication—does that mean I can't use compounded ED treatment?
A: Not automatically. According to approved ED drug labels, PDE5 inhibitors add to the blood-pressure-lowering effects of antihypertensives. Your prescriber and cardiologist must discuss whether this combination is safe for your specific situation and medications. This is a conversation between your providers, not a yes-or-no answer on your own.
Q: What should I tell my telehealth prescriber to get a safe review?
A: Bring your complete medication list (prescriptions, over-the-counter, supplements) and your full cardiac and medical history. If the telehealth visit does not include a thorough medication review or does not address your heart health, you may want a second opinion from your primary care doctor or cardiologist before starting treatment.
Q: If I've had a heart attack, can I use a compounded ED medication?
A: This is a question for your cardiologist, not the telehealth visit. Your cardiologist must evaluate your current heart function and the overall cardiac risk of sexual activity before any ED treatment is started. Approved PDE5 labels direct this screening. Do not start compounded or any other ED treatment without individual prescriber and cardiac assessment.
This article is for educational purposes and does not replace medical advice from your cardiologist, prescriber, or emergency service. Compounded medications are not FDA-approved, and the sources reviewed for this article did not include a clinical trial of the exact compounded combinations and routes discussed here. Always inform all your providers (cardiologist, primary care, prescriber, pharmacist) about compounded ED products you are considering or taking. In the event of a medical emergency, call 911 immediately. Source date: August 5, 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement, medication, or treatment program. Individual results may vary.